Valvular & structural heart disease

The first International Consortium for Health Outcomes Measurement (ICHOM) standard dataset for reporting outcomes in heart valve disease: moving from device- to patient- centered outcomes

Eur Heart J Qual Care Clin OutcomesPublished online modified Delphi process

Authors' conclusion

Through a unique collaborative effort between patients and cardiology and cardiothoracic surgery societies, a standard set of measures for HVD was developed. This dataset focuses on outcome measurement regardless of treatment, moving from procedure- to patient-centered outcomes. Implementation of this dataset will facilitate global standardization of outcome measurement, allow meaningful comparison between health care systems and evaluation of clinical practice guidelines, and eventually improve patient care for those experiencing HVD worldwide.

Study context

Population
Patients with aortic/mitral/tricuspid valve disease or root/ascending aorta >40 mm
Methodological detailsmultisociety working group, benchmark analyses and systematic reviews
  • Multisociety working group
  • Benchmark analyses and systematic reviews

Main finding

As reported in the abstract

Outcome domains

Outcome domains: vital status, patient-reported outcomes, progression of disease, cardiac function and durability, and complications of treatment

5

Further findings

Outcome measures selected

Outcome measures
16
Patient-reported outcomes among them
2

Case-mix variables

Demographic factors, demographic variables, echocardiographic variables, heart catheterization variables, and specific details on aortic/mitral/tricuspid valves and their specific interventions

Original publication

The first International Consortium for Health Outcomes Measurement (ICHOM) standard dataset for reporting outcomes in heart valve disease: moving from device- to patient- centered outcomes. Eur Heart J Qual Care Clin Outcomes. Published 17 February 2025. doi:10.1093/ehjqcco/qcae051

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.